Everything you need to win GT Medical — in one platform.
Who to reach, what to say, and why now on GT Medical — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on GT Medical — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
The decision-maker’s email and mobile — dial in-browser.
GT Medical raises $100M for brain tumor tech after clinical trial success. The funding will support the development of their bioresorbable device used in tumor removal surgery.
PRIVATEJun 10, 2026•4 days ago
Amount Raised
$100 Million
BiotechnologyHealth CareMedicalMedical Device
Description
GT Medical has raised $100 million to further develop its innovative brain tumor technology following successful clinical trials. The funding will enable the company to advance their bioresorbable device, designed to deliver targeted radiation during tumor surgery. This device aims to eliminate residual cancer cells when they are at their lowest levels. The investment underscores confidence in GT Medical’s potential impact on cancer treatment.
Company Information
Company
GT Medical
About
GT Medical is focused on developing innovative solutions for brain tumor treatment. Their bioresorbable device is designed to be used during tumor removal surgery to facilitate targeted radiation therapy. This technology aims to improve outcomes by eliminating residual cancer cells after surgery. The company has recently achieved significant funding, indicating strong confidence in their approach.
